|
WO2011103490A2
(en)
|
2010-02-18 |
2011-08-25 |
The Regents Of The University Of California |
INTEGRIN αVβ8 NEUTRALIZING ANTIBODY
|
|
US20140079722A1
(en)
*
|
2011-03-09 |
2014-03-20 |
Centrose, Llc |
Extracellular targeted drug conjugates
|
|
WO2013023162A2
(en)
*
|
2011-08-10 |
2013-02-14 |
Genus Oncology, Llc |
Anti-muc1 antibodies for cancer diagnostics
|
|
MX350335B
(es)
|
2011-08-17 |
2017-09-04 |
Univ California |
Anticuerpos que enlazan alfa-v beta-8 integrina.
|
|
US12466897B2
(en)
|
2011-10-10 |
2025-11-11 |
Xencor, Inc. |
Heterodimeric human IgG1 polypeptides with isoelectric point modifications
|
|
CN102786595B
(zh)
*
|
2012-08-03 |
2014-04-23 |
无锡傲锐东源生物科技有限公司 |
抗cd5蛋白单克隆抗体及其用途
|
|
WO2014100740A1
(en)
|
2012-12-21 |
2014-06-26 |
Seattle Genetics, Inc. |
Anti-ntb-a antibodies and related compositions and methods
|
|
SG11201504920SA
(en)
*
|
2012-12-27 |
2015-07-30 |
Sanofi Sa |
Anti-lamp1 antibodies and antibody drug conjugates, and uses thereof
|
|
KR102391731B1
(ko)
|
2013-01-14 |
2022-04-27 |
젠코어 인코포레이티드 |
신규한 이형이량체 단백질
|
|
US10858417B2
(en)
|
2013-03-15 |
2020-12-08 |
Xencor, Inc. |
Heterodimeric proteins
|
|
SG10201806481XA
(en)
*
|
2014-02-19 |
2018-09-27 |
Emergent Biosolutions Canada Inc |
Marburg monoclonal antibodies
|
|
HK1245171A1
(zh)
|
2014-11-26 |
2018-08-24 |
Xencor, Inc. |
结合cd3和cd38的异二聚体抗体
|
|
JP6696982B2
(ja)
|
2014-11-26 |
2020-05-20 |
ゼンコー・インコーポレイテッドＸｅｎｃｏｒ、 Ｉｎｃ． |
Ｃｄ３および腫瘍抗原に結合するヘテロ二量体抗体
|
|
US10259887B2
(en)
|
2014-11-26 |
2019-04-16 |
Xencor, Inc. |
Heterodimeric antibodies that bind CD3 and tumor antigens
|
|
US20170151281A1
(en)
|
2015-02-19 |
2017-06-01 |
Batu Biologics, Inc. |
Chimeric antigen receptor dendritic cell (car-dc) for treatment of cancer
|
|
MA41962A
(fr)
|
2015-04-23 |
2018-02-28 |
Baylor College Medicine |
Récepteur antigénique chimérique ciblant le cd5 pour une thérapie adoptive à base de cellules t
|
|
WO2017214285A1
(en)
*
|
2016-06-07 |
2017-12-14 |
Eynav Klechevsky |
Detection of cd5 and methods and compositions for modulating cd5
|
|
RU2019102008A
(ru)
|
2016-06-28 |
2020-07-28 |
Ксенкор, Инк. |
Гетеродимерные антитела, которые связывают рецептор соматостатина 2-го типа
|
|
WO2018017864A2
(en)
*
|
2016-07-20 |
2018-01-25 |
Oncomed Pharmaceuticals, Inc. |
Pvrig-binding agents and uses thereof
|
|
SI4339615T1
(sl)
*
|
2016-09-16 |
2026-01-30 |
Shanghai Henlius Biotech, Inc. |
Protitelesa anti-pd-1 za uporabo pri zdravljenju raka
|
|
US20180128545A1
(en)
|
2016-11-08 |
2018-05-10 |
Berry Metal Company |
Modular furnace cooling wall
|
|
AU2018366199A1
(en)
|
2017-11-08 |
2020-05-28 |
Xencor, Inc. |
Bispecific and monospecific antibodies using novel anti-PD-1 sequences
|
|
AU2018374283B2
(en)
|
2017-11-29 |
2025-09-18 |
Magenta Therapeutics, Inc. |
Compositions and methods for the depletion of CD5+ cells
|
|
CN112469477A
(zh)
|
2018-04-04 |
2021-03-09 |
Xencor股份有限公司 |
与成纤维细胞活化蛋白结合的异源二聚体抗体
|
|
WO2019204507A1
(en)
|
2018-04-18 |
2019-10-24 |
Biomadison, Inc. |
Methods for determining vaccine potency
|
|
KR102559149B1
(ko)
|
2018-10-26 |
2023-07-24 |
에프. 호프만-라 로슈 아게 |
재조합효소 매개 카세트 교환을 이용한 다중특이적 항체 스크리닝 방법
|
|
EP3876977A1
(en)
|
2018-11-06 |
2021-09-15 |
The Regents Of The University Of California |
Chimeric antigen receptors for phagocytosis
|
|
AU2019404302A1
(en)
|
2018-12-19 |
2021-08-05 |
The Trustees Of The University Of Pennsylvania |
Use of CD2/5/7 knock-out anti-CD2/5/7 chimeric antigen receptor t cells against t cell lymphomas and leukemias
|
|
CA3131096A1
(en)
|
2019-04-05 |
2020-10-08 |
Chi-Huey Wong |
Sialidase-resistant saccharide and method of making and using the same
|
|
WO2020216947A1
(en)
|
2019-04-24 |
2020-10-29 |
Heidelberg Pharma Research Gmbh |
Amatoxin antibody-drug conjugates and uses thereof
|
|
US11026973B2
(en)
|
2019-04-30 |
2021-06-08 |
Myeloid Therapeutics, Inc. |
Engineered phagocytic receptor compositions and methods of use thereof
|
|
WO2021046243A2
(en)
|
2019-09-03 |
2021-03-11 |
Myeloid Therapeutics, Inc. |
Methods and compositions for genomic integration
|
|
US10980836B1
(en)
|
2019-12-11 |
2021-04-20 |
Myeloid Therapeutics, Inc. |
Therapeutic cell compositions and methods of manufacturing and use thereof
|
|
CA3182526A1
(en)
|
2020-05-08 |
2021-11-11 |
Academia Sinica |
Chimeric influenza vaccines
|
|
WO2021231976A1
(en)
|
2020-05-14 |
2021-11-18 |
Xencor, Inc. |
Heterodimeric antibodies that bind prostate specific membrane antigen (psma) and cd3
|
|
WO2021231982A1
(en)
*
|
2020-05-14 |
2021-11-18 |
City Of Hope |
Smc1a antibodies and uses thereof
|
|
EP4149632A1
(en)
|
2020-05-14 |
2023-03-22 |
Xencor, Inc. |
Heterodimeric antibodies that bind msln and cd3
|
|
EP3915641A1
(en)
*
|
2020-05-27 |
2021-12-01 |
International-Drug-Development-Biotech |
Anti-cd5 antibodies and methods of use thereof
|
|
JP2023538108A
(ja)
*
|
2020-08-21 |
2023-09-06 |
シティ・オブ・ホープ |
抗ｃｄ５抗体組成物及びその使用
|
|
EP4211245A1
(en)
|
2020-09-14 |
2023-07-19 |
Vor Biopharma Inc. |
Compositions and methods for cd5 modification
|
|
EP4240367A4
(en)
|
2020-11-04 |
2024-10-16 |
Myeloid Therapeutics, Inc. |
MODIFIED CHIMERIC FUSION PROTEIN COMPOSITIONS AND METHODS OF USE THEREOF
|
|
WO2022099090A1
(en)
*
|
2020-11-06 |
2022-05-12 |
Xencor, Inc. |
Heterodimeric antibodies that bind tgfbrii
|
|
CN116801905A
(zh)
*
|
2020-12-17 |
2023-09-22 |
先声再明医药有限公司 |
Cd5抗体及其应用
|
|
WO2022152185A1
(zh)
*
|
2021-01-12 |
2022-07-21 |
南京驯鹿医疗技术有限公司 |
靶向cd5的全人源抗体
|
|
AU2022218137A1
(en)
|
2021-02-03 |
2023-08-24 |
Mozart Therapeutics, Inc. |
Binding agents and methods of using the same
|
|
EP4305067A1
(en)
|
2021-03-09 |
2024-01-17 |
Xencor, Inc. |
Heterodimeric antibodies that bind cd3 and cldn6
|
|
US11859012B2
(en)
|
2021-03-10 |
2024-01-02 |
Xencor, Inc. |
Heterodimeric antibodies that bind CD3 and GPC3
|
|
WO2022221837A2
(en)
|
2021-04-12 |
2022-10-20 |
Academia Sinica |
Improved coronavirus vaccine
|
|
EP4332118A1
(en)
*
|
2021-04-29 |
2024-03-06 |
Korea Research Institute of Bioscience and Biotechnology |
Novel anti-cd5 chimeric antigen receptor and immune cell expressing same
|
|
WO2022241029A1
(en)
|
2021-05-11 |
2022-11-17 |
Myeloid Therapeutics, Inc. |
Methods and compositions for genomic integration
|
|
CN113105547B
(zh)
*
|
2021-05-18 |
2022-04-08 |
福州迈新生物技术开发有限公司 |
抗cd5蛋白单克隆抗体及其细胞株、制备方法和应用
|
|
TW202334429A
(zh)
|
2021-10-01 |
2023-09-01 |
中央研究院 |
Sars-cov-2棘蛋白特異性抗體及其用途
|
|
WO2023076876A1
(en)
|
2021-10-26 |
2023-05-04 |
Mozart Therapeutics, Inc. |
Modulation of immune responses to viral vectors
|
|
US12077597B2
(en)
|
2021-11-24 |
2024-09-03 |
International-Drug-Development-Biotech |
Anti-CD5 antibodies and methods of use thereof
|
|
US20230279080A1
(en)
*
|
2021-12-27 |
2023-09-07 |
Academia Sinica |
Antibody specific to spike protein of sars-cov-2 and uses thereof
|
|
WO2024039683A1
(en)
*
|
2022-08-15 |
2024-02-22 |
Myeloid Therapeutics, Inc. |
Compositions and methods for conditioning patients for cell therapy
|
|
WO2024040195A1
(en)
|
2022-08-17 |
2024-02-22 |
Capstan Therapeutics, Inc. |
Conditioning for in vivo immune cell engineering
|
|
NZ825394A
(en)
|
2023-04-08 |
2026-03-27 |
Rock Biomedical Inc |
Methods and compositions for dendritic cell targeting nano-delivery
|
|
CA3268566A1
(en)
|
2023-04-08 |
2024-10-17 |
Rock Biomedical Inc. |
METHODS AND COMPOSITIONS FOR TARGETED DISTRIBUTION BY POLYMERSOMES
|
|
CN121175414A
(zh)
|
2023-05-17 |
2025-12-19 |
磐石医药生技股份有限公司 |
Mgat1缺乏细胞及其用途
|
|
EP4719352A1
(en)
|
2023-05-31 |
2026-04-08 |
Capstan Therapeutics, Inc. |
Lipid nanoparticle formulations and compositions
|
|
WO2024258967A1
(en)
*
|
2023-06-13 |
2024-12-19 |
Synthis Therapeutics, Inc. |
Anti-cd5 antibodies and their uses
|
|
US20250127728A1
(en)
|
2023-10-05 |
2025-04-24 |
Capstan Therapeutics, Inc. |
Constrained Ionizable Cationic Lipids and Lipid Nanoparticles
|
|
WO2025076113A1
(en)
|
2023-10-05 |
2025-04-10 |
Capstan Therapeutics, Inc. |
Ionizable cationic lipids with conserved spacing and lipid nanoparticles
|
|
WO2025149667A1
(en)
|
2024-01-12 |
2025-07-17 |
Pheon Therapeutics Ltd |
Antibody drug conjugates and uses thereof
|
|
US20250302763A1
(en)
|
2024-02-22 |
2025-10-02 |
Capstan Therapeutics, Inc. |
Immune engineering amplification
|
|
WO2025217454A2
(en)
|
2024-04-11 |
2025-10-16 |
Capstan Therapeutics, Inc. |
Ionizable cationic lipids and lipid nanoparticles
|
|
WO2025217452A1
(en)
|
2024-04-11 |
2025-10-16 |
Capstan Therapeutics, Inc. |
Constrained ionizable cationic lipids and lipid nanoparticles
|
|
WO2025220805A1
(ko)
*
|
2024-04-18 |
2025-10-23 |
주식회사 큐로셀 |
신규한 항-cd5 키메릭 항원 수용체 및 이의 용도
|